Pharmaceutical or veterinary compositions containing thiosulfonate derivatives
US4694015A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Nov 13, 1985 |
| Grant date | Sep 15, 1987 |
| Priority date | — |
| Expiry date | Nov 13, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical or veterinary compositions for initing the malformation or destruction of red blood corpuscules due to a genetic modification of haemoglobin or to parasites, compositions comprising, as active ingredient, at least one thiosulfonate derivative of general formula: EQU R--S--SO.sub.2 --R.sub.1 in which R represents a 1-methyl-imidazol-2-yl, 1H-benzimidazol-2-yl or benzoxazol-2-yl radical and R.sub.1 represents a lower alkyl, (hydroxy) lower alkyl, lower alkanoyl, phenyl, (lower alkyl) phenyl, (hydroxy lower alkyl) phenyl, (lower alkanoyl) phenyl or quinolin-8-yl radical. The compositions in question can be used in the treatment of drepanocytosis, malaria and babebiosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.